Legal Representation
Attorney
Thomas G. Peterson
USPTO Deadlines
Next Deadline
705 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-10-12)
Due Date
October 12, 2027
Grace Period Ends
April 12, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 27, 2022 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Oct 12, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 9, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Sep 8, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Aug 3, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Aug 3, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 3, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 30, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 21, 2021 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Jul 21, 2021 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 21, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 22, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jun 17, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 8, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jun 8, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Dec 8, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 13, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 13, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 23, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 10, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 9, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 8, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 8, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 18, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 18, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 18, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 12, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 28, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 18, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Scientific, medical and pharmaceutical research and development, namely, development of new pharmaceutical formulations, development of pharmaceutical formulations for efficient drug release, development of clinical uses and treatments for new chemical entities and known pharmaceutical compounds; research and development of new pharmaceutical formulations; research and development of pharmaceutical formulations for efficient drug release; research and development of pharmaceuticals, namely, pharmaceuticals for treating cancer, multiple sclerosis, cystic fibrosis, tuberous sclerosis complex, and other disease states; research and development of new chemical entities and known pharmaceutical compounds; research and development of medicines, namely, for the treatment of cancer, multiple sclerosis, cystic fibrosis, tuberous sclerosis complex, and other disease states; scientific investigations for medical purposes; research and development of medicines, namely, new chemical entities and known pharmaceutical compounds
First Use Anywhere:
Sep 1, 2020
First Use in Commerce:
Sep 1, 2020
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"